AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 82 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2020. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $428,000 | -37.7% | 85,000 | 0.0% | 0.00% | -42.9% |
| Q2 2020 | $687,000 | +329.4% | 85,000 | +37.1% | 0.01% | +250.0% |
| Q4 2018 | $160,000 | -41.2% | 62,000 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $272,000 | -28.4% | 62,000 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $380,000 | -15.9% | 62,000 | 0.0% | 0.01% | -25.0% |
| Q1 2018 | $452,000 | -11.0% | 62,000 | 0.0% | 0.01% | -11.1% |
| Q4 2017 | $508,000 | -56.4% | 62,000 | -44.1% | 0.01% | -55.0% |
| Q3 2017 | $1,166,000 | -4.7% | 111,000 | 0.0% | 0.02% | -13.0% |
| Q2 2017 | $1,224,000 | +13.9% | 111,000 | 0.0% | 0.02% | +9.5% |
| Q1 2017 | $1,075,000 | – | 111,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 3,102,673 | $4,468,000 | 0.92% |
| JW Asset Management, LLC | 444,439 | $640,000 | 0.33% |
| BRANDES INVESTMENT PARTNERS, LP | 7,052,720 | $10,157,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,722,241 | $3,920,000 | 0.15% |
| Tekla Capital Management LLC | 814,588 | $1,173,000 | 0.05% |
| INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV | 34,750 | $50,000 | 0.04% |
| Brown Capital Management | 1,400,007 | $2,016,000 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 843,975 | $1,217,000 | 0.01% |
| WEDBUSH SECURITIES INC | 35,535 | $51,000 | 0.01% |
| Close Asset Management Ltd | 15,000 | $22,000 | 0.00% |